Genes, germs, and schizophrenia: An evolutionary perspective

Perspectives in Biology and Medicine

Volumn 46, Issue 3, 2003, Pages 317-348

  Ledgerwood, Levi G ^a,b   Ewald, Paul W ^a,c   Cochran, Gregory M ^d  

^a AMHERST COLLEGE   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; HUMAN; INFECTION; INTRAUTERINE INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TOXOPLASMA GONDII;

PROTOZOA; TOXOPLASMA GONDII;

EID: 0041866512     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2003.0038     Document Type: Review

References (211)

1. Akbarian, S., et al. 1993. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry 50:178-87.
2. Anderson, M. L., B. C. Barr, and P. A. Conrad. 1994. Protozoal causes of reproductive failure in domestic ruminants. Vet. Clin. North Am. Food Anim. Pract. 10:439-61.
3. Arnott, M. A., et al. 1990. Social interactions of mice with congenital Toxoplasma infection. Ann. Trop. Med. Parasitol. 84:149-56.
4. Baron, M. 2001. Genetics of schizophrenia and the new millennium: Progress and pitfalls. Am. J. Hum. Genet. 68:299-312.
5. Bassett, A. S., et al. 1996. Reproductive fitness in familial schizophrenia. Schizophr. Res. 21:151-60.
6. Battle, Y. L., et al. 1999. Seasonality and infectious disease in schizophrenia: The birth hypothesis revisited. J. Psychiatr. Res. 33:501-9.
7. Bennedsen, B. E., et al. 2001. Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch. Gen. Psychiatry 58:674-79.
8. Berdoy, M., J. P. Webster, and D.W. MacDonald. 2000. Fatal attraction in rats infected with Toxoplasma gondii. Proc. R. Soc. Lond. B Biol. Sci. 267:1591-94.
9. Bernstein, H.-G., et al. 1998. Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83:867-75.
10. Beverley, J. K. A. 1959. Congenital transmission of toxoplasmosis through successive generations of mice. Nature 183:1348-49.
11. Beverley, J. K. A., W. A. Watson, and J. B. Spence. 1971. The pathology of the foetus in ovine abortion due to toxoplasmosis. Vet. Rec. 88:174-78.
12. Black, M. D., et al. 1999. On the effect of neonatal nitric oxide synthase inhibition in rats: A potential neurodevelopmental model of schizophrenia. Neuropharmacology 38:1299-1306.
13. Bourne, G. 1962. The human amnion and chorion. London: Lloyd-Luke.
14. Brown, A. E., et al. 2000. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: A prospective birth cohort study. Schizophr. Bull. 26:287-95.
15. Buka, S. L. 2000. Potential applications of the National Collaborative Perinatal Project for the study of toxoplasma infections and psychiatric disease. Presented at the Stanley Symposium, Toxoplasma Infection and Schizophrenia, Johns Hopkins University, November 2000.
16. Buka, S. L., et al. 2001. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 58:1032-37.
17. Cadenhead, K. S., et al. 2000. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits. Am. J. Psychiatry 157:1660-68.
18. Camus, D., et al. 1995. The art of parasite survival. Braz. J. Med. Biol. Res. 28:399-413.
19. Castrogiovanni, P., et al. 1998. Season of birth in psychiatry. Neuropsychobiology 37:175-81.
20. Cochran, G. M., P.W. Ewald, and K. D. Cochran. 2000. Infectious causation of disease:An evolutionary perspective. Perspect. Biol. Med. 43:406-48.
21. Cohen, B.A. 1999. Neurologic manifestations of toxoplasmosis in AIDS. Sem. Neurol. 19:201-11.
22. Contreras, M. C., et al. 2000. Diagnostic use of ELISA, IgG, IgM, IgA and ELISA IgG avidity in recent and chronic toxoplasmosis. Bol. Chil. Parasitol. 55:17-24.
23. Cook, A.J.C., et al. 2000. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 321:142-47.
24. Cooper, B. 2001. Nature, nurture and mental disorder: Old concepts in the new millennium. Br. J. Psychiatry 178:S91-102.
25. Couvreur, J., G. Desmonts, and J.Y. Girre. 1976. Congenital toxoplasmosis in twins: A series of 14 pairs of twins: Absence of infection in one twin in two pairs. J. Pediatr. 89:235-40.
26. Crocker, I., et al. 1999. Significance of fatty acids in pregnancy-induced immunosuppression. Clin. Diagn. Lab. Immunol. 6:587-93.
27. Curtis, C. E., et al. 2001. Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives. Am. J. Psychiatry 158:100-106.
28. Dale, P.W. 1981. Prevalence of schizophrenia in the Pacific island populations of Micronesia. J. Psychiatr. Res. 16:103-11.
29. Dalén, P. 1988. Schizophrenia, season of birth, and maternal age. Br. J. Psychiatry 153:727-33.
30. Danforth, D. N., et al. 1986. Obstetrics and gynecology. Philadelphia: Lippincott Williams and Wilkins.
31. Davis, J. O., J. A. Phelps, and H. S. Bracha. 1995. Prenatal development of monozygotic twins and concordance for schizophrenia. Schiz. Bull. 21:337-66.
32. DeLisi, L. E., et al. 2002. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry 159:803-12.
33. Desmonts, G., and J. Couvreur. 1979. Congenital toxoplasmosis: A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. Pathophysiology of congenital disease. In Perinatal medicine: Sixth European Congress, Vienna, ed. O. Thalhammer, V. Baumgarten, and A. Pollak. Stuttgart: Georg Thieme.
34. Desolme, B., et al. 2000. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18:2512-21.
35. Destounis, N. 1966. The relationship between schizophrenia and toxoplasmosis. Del. Med. J. 38:349-51.
36. Dubey, J. P. 1981. Toxoplasma-induced abortion in dairy goats. J. Am. Vet. Assoc. 178:671-74.
37. Dubey, J. P., and S. P. Sharma, 1980. Prolonged excretion of Toxoplasma gondii in semen of goats. Am. J. Vet. Res. 41:794-95.
38. Eberhart-Phillips, J. E., et al. 2001. Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders. Sex. Transm. Infect. 77:353-57.
39. Egberongbe, Y. I., et al. 1994.The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59:561-78.
40. Elias, J. M., et al. 1960. Toxoplasmosis as an aetiological factor in the determination of neuro-psychic affections in children. Rum. Med. Rev. 4:41-44.
41. Elsaid, M. M., et al. 2001.Vertical toxoplasmosis in a murine model: Protection after immunization with antigens of Toxoplasma gondii incorporated into liposomes. Mem. Inst. Oswaldo Cruz 96:99-104.
42. Essen-Möller, E., and M. Fischer. 1979. Do the partners of dizygotic schizophrenic twins run a greater risk of schizophrenia than ordinary siblings? Hum. Hered. 29:161-65.
43. Ewald, P.W. 1995. The evolution of virulence: A unifying link between parasitology and ecology. J. Parasitol. 81:659-69.
44. Ewald, P.W., and G. M. Cochran. 2000. Chlamydia pneumoniae and cardiovascular disease: An evolutionary perspective on infectious causation and antibiotic treatment. J. Infect. Dis. 181:S394-401.
45. Fañanás, L., and J. Bertranpetit. 1995. Reproductive rates in families of schizophrenic patients in a case-control study. Acta. Psychiatr. Scand. 91:202-4.
46. Fatemi, S. H. 2001. Reelin mutations in mouse and man: From reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol. Psychiatry 6:129-33.
47. Feldman, H.A. 1982. Epidemiology of Toxoplasma infections. Epidemiol. Rev. 4:204-13.
48. Feldman, H.A., and L.T. Miller. 1956a. Congenital human toxoplasmosis. Ann. NY Acad. Sci. 64:180-84.
49. Feldman, H. A., and L. T. Miller. 1956b. Serological study of toxoplasmosis prevalence. Am. J. Hyg. 64:320-35.
50. Flegr, J., and I. Hrdy. 1994. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 41:122-26.
51. Flegr, J., et al. 1996. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 113:49-54.
52. Forther, B., et al. 1991. Spontaneous abortion and reinfection by Toxoplasma gondii. Lancet 338:444.
53. Foulon, W., A. Naessens, and D. Ho-Yen. 2000. Prevention of congenital toxoplasmosis. J. Perinat. Med. 28:337-45.
54. Frenkel, J. K. 1951. Pathology of chronic toxoplasmosis in the golden hamster. Am. J. Pathol. 27:746-47.
55. Frenkel, J. K. 1956. Pathogenesis of toxoplasmosis and of infections with organisms resembling toxoplasma. Ann. NY Acad. Sci. 64:215-51.
56. Frenkel, J. K. 1966. Some data on the incidence of human toxoplasmosis as a cause of mental retardation. In The prevention of mental retardation through control of infectious diseases, ed. H. F. Eichenwald. Bethesda: National Institute of Health Publications.
57. Frenkel, J. K. 1973a. Toxoplasma in and around us. Bioscience 23:343-52.
58. Frenkel, J. K. 1973b. Toxoplasmosis: Parasite lifecycle, pathology, and immunology. In The Coccidia: Eimeria, Isopora, Toxoplasma, and related genera, ed. D. M. Hammond and P. L. Long. Baltimore: University Park Press.
59. Fux, B., et al. 2000. Experimental toxoplasmosis in Balb/c mice: Prevention of vertical disease transmission by treatment and reproductive failure in chronic infection. Mem. Inst. Oswaldo Cruz 95:121-26.
60. Garcia, A. G. P. 1968. Congenital toxoplasmosis in two successive sibs. Arch. Dis. Childh. 43:705-10.
61. Gilbert, R. E., et al. 2001. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: Retrospective cohort study of 554 mother-child pairs in Lyon, France. Int. J. Epidemiol. 30:1303-08.
62. Gomez-Marin, J. E., et al. 2000. Frequency of specific anti-Toxoplasma gondii IgM, IgA and IgE in Colombian patients with acute and chronic ocular toxoplasmosis. Mem. Inst. Oswaldo Cruz 95:89-94.
63. Gottesman, I. I. 1994. Schizophrenia epigenesis: Past, present, and future. Acta. Psychiatr. Scand. 90:S26-33.
64. Gualandi, G., et al. 2001. Enhancement of genetic instability in human B cells by Epstein-Barr virus latent infection. Mutagenesis 16:203-08.
65. Guggenheim, F. G., et al. 1969. Prevalence of physical illness in parents of identical twins discordant for schizophrenia. Psychosom. Med. 31:288-99.
66. Haukka, J., et al. 2001. Regional variation in the incidence of schizophrenia in Finland: A study of birth cohorts born from 1950 to 1969. Psychol. Med. 31:1045-53.
67. Havlícek, J., et al. 2001. Decrease of psychomotor performance in subjects with latent "asymptomatic" toxoplasmosis. Parasitology 122:515-20.
68. Hay, J., et al. 1983. The effect of congenital and adult acquired Toxoplasma infections on activity and responsiveness to novel stimulation in mice. Ann. Trop. Med. Parasitol. 77:483-95.
69. Hayashi, S., et al. 1996. Contributions of nitric oxide to the host parasite equilibrium in toxoplasmosis. J. Immunol. 156:1476-81.
70. Hayde, M., and A. Pollak. 2000. Clinical picture: Neonatal signs and symptoms. In Congenital toxoplasmosis: Scientific background, clinical management and control, ed. P. Ambroise-Thomas and E. Petersen. Paris: Springer-Verlag.
71. Heath, R. G., A. F. Guschwan, and J. W. Coffey. 1970. Relation of taraxein to schizophrenia. Dis. Nerv. Syst. 31:391-95.
72. Heath, R. G., and I. M. Krupp. 1968. Schizophrenia as a specific biologic disease. Am. J. Psychiatry 124:37-45.
73. Heath, R. G., et al. 1967. Schizophrenia as an immunologic disorder. III. Effects of antimonkey and antihuman brain antibody on brain function. Arch. Gen. Psychiatry 16:24-33.
74. Heath, R. G., et al. 1957. Effect on behavior in humans with the administration of taraxein. Am. J. Psychiatry 114:4-24.
75. Ho-Yen, D. O., and A. W. L. Joss. 1992. Human toxoplasmosis. Oxford: Oxford Univ. Press.
76. Hoff, E. F., et al. 2001. Toxoplasma gondii: Molecular cloning and characterization of a novel 18-kDa secretory antigen, TgMIC10. Exp. Parasitol. 97:77-88.
77. Holliman, R. E. 1997. Toxoplasmosis, behaviour and personality. J. Infect. 35:105-10.
78. Hotson, J. R. 1981. Modern neurosyphilis: A partially treated chronic meningitis. West. J. Med. 135:191-200.
79. Hrda, S., et al. 2000. Transient nature of Toxoplasma gondii-induced behavioral changes in mice. J. Parasitol. 86:657-63.
80. Hutchison, W. M., P. P. Aitken, and B. W. P. Wells. 1980. Chronic Toxoplasma infections and motor performance in the mouse. Ann. Trop. Med. Parasitol. 74:507-10.
81. Hutchison, W. M., et al. 1980. Behavioural abnormalities in Toxoplasma-infected mice. Ann. Trop. Med. Parasitol. 74:337-45.
82. Imamura, A., et al. 2001. Lack of association between the hKCa3 gene and Japanese schizophrenia patients. Psychiatr. Genet. 11:227-29.
83. Ingraham, L.J., and S. S. Kety. 2000. Adoption studies of schizophrenia. Am. J. Med. Genet. 97:18-22.
84. Iwahashi, K., et al. 1998. Positive and negative syndromes, and Borna disease virus infection in schizophrenia. Neuropsychobiology 37:59-64.
85. Jackson, M. H., and W. M. Hutchison. 1989. The prevalence and source of Toxoplasma infection in the environment. Adv. Parasitol. 28:55-105.
86. Jeste, D.V., et al. 1985. Did schizophrenia exist before the eighteenth century? Compr. Psychiatry 26:493-503.
87. Jones, J. L., et al. 2001. Congenital toxoplasmosis: A review. Obstet. Gynecol. Surv. 56:296-305.
88. Karson, C. N., et al. 1996. Nitric oxide synthase (NOS) in schizophrenia: Increases in cerebellar vermis. Mol. Chem. Neuropathol. 27:275-84.
89. Kelemen, A. 1977. Maternal age at conception of children who became schizophrenic in their adult lives. Act. Nerv. Super. (Praha) 19:S381.
90. Kennedy, J. L., et al. 1988. Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 336:167-70.
91. Khan, I. A., et al. 1997. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA 94:13955-60.
92. Khan, I.A., et al. 2001. Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection. J. Immunol. 166:1930-37.
93. Kidd, M., and I. M. Modlin. 1998. A century of Helicobacter pylori: Paradigms lost - paradigms regained. Digestion 59:1-15.
94. Kiloh, L. G. 1975. Psychiatry amongst Australian aborigines. Br. J. Psychiatry 126:1-10.
95. Kimball, A. C., B. H. Kean, and F. Fuchs. 1971. The role of toxoplasmosis in abortion. Am. J. Obstet. Gynecol. 111:219-26.
96. Kirkpatrick, B., et al. 1998. Summer birth and the deficit syndrome of schizophrenia. Am. J. Psychiatry 155:1221-26.
97. Kirkpatrick, B., et al. 2001. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 58:165-71.
98. Kirkpatrick, B., et al. 2002. Summer birth and deficit schizophrenia in Dumfries and Galloway, southwestern Scotland. Am. J. Psychiatry 159:1382-87.
99. Kjaergaard, N., et al. 1999. Chorioamniotic membranes constitute a competent barrier to group b streptococcus in vitro. Eur. J. Obstet. Gynecol. Reprod. Biol. 83:165-69.
100. Kläning, U. 1999. Greater occurrence of schizophrenia in dizygotic but not monozygotic twins. Br. J. Psychiatry 175:407-9.
101. Kohler, C. G., J. Pickholtz, and C. Ballas. 2000. Neurosyphilis presenting as schizophrenialike psychosis. Neuropsychiatry Neuropsychol. Behav. Neurol. 13:297-302.
102. Koppe, J. G., D. H. Loewer-Sieger, and H. de Roever-Bonnet. 1986. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1 (8475):254-56.
103. Koppe, J. G., and A. Rothova. 1989. Congenital toxoplasmosis: A long-term follow-up of 20 years. Int. Opthamol. 13:387-90.
104. Kringlen, E. 2000. Twin studies in schizophrenia with special emphasis on concordance figures. Am. J. Med. Genet. 97:4-11.
105. Kristensen, P., et al. 1997. Gestational age, birth weight, and perinatal death among births to Norwegian farmers, 1967-1991. Am. J. Epidemiol. 146:329-38.
106. Ladee, G. A., J. M. Scholten, and F. E. P. Meyes. 1966. Diagnostic problems in psychiatry with regard to acquired toxoplasmosis. Psychiat. Neurol. Neuroch. 69:65-82.
107. Langs, R. J., and H. L. Barr. 1968. Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. J. Nerv. Ment. Dis. 147:163-72.
108. Lappalainen, M., et al. 1995. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. Pediatric Infect. Dis. J. 14:354-61.
109. Lauer, M., D. Senitz, and H. Beckmann. 2001. Increased volume of the nucleus accumbens in schizophrenia. J. Neural. Transm. 108:645-60.
110. Levinson, D. F., et al. 2002. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 296:739-41.
111. Lieberman, J., et al. 2001. Longitudinal study of brain morphology in first episode schizophrenia. Biol. Psychiatry 49:487-99.
112. Liesenfeld, O., et al. 2001. Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am. J. Obstet. Gynecol. 184:140-45.
113. Liu, H., et al. 2002. Genetic variation at the 22q11 PKODH2/DGCK6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. USA 99:3717-22.
114. Livezey, K. W., and D. Simon. 1997. Accumulation of genetic alterations in a human hepatoma cell line transfected with hepatitis B virus. Mutat. Res. 377:187-98.
115. Lobato, M. I., et al. 2001. Neurodevelopmental risk factors in schizophrenia. Braz. J. Med. Biol. Res. 34:155-63.
116. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-22.
117. Mack, D.G., et al. 1999. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int. J. Parasitol. 29:1351-58.
118. Malaspina, D., et al. 2001. Advancing paternal age and the risk of schizophrenia. Arch. Gen. Psychiatry 58:361-67.
119. Mallard, E. C., et al. 1999. Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: Implications for the aetiology of schizophrenia. Schizophr. Res. 40:11-21.
120. Maricle, R. A., et al. 1987. The prevalence and significance of medical illness among chronically mentally ill outpatients. Comm. Ment. Health. J. 23:81-90.
121. Mateus-Pinilla, N. E., et al. 1999. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J. Parasitol. 85:855-60.
122. Mathalon, D. H., et al. 2001. Progressive brain volume changes and the clinical course of schizophrenia in men. Arch. Gen. Psychiatry 58:148-57.
123. Mathew, M. J., and M. J. Chandy. 1999. Central nervous system toxoplasmosis in Acquired Immunodeficiency Syndrome: An emerging disease in India. Neurol. India 47:182-87.
124. Matsumoto, H., et al. 2001. Superior temporal gyrus abnormalities in early-onset schizophrenia: Similarities and differences with adult-onset schizophrenia. Am. J. Psychiatry 158:1299-1304.
125. McDougall, J. K. 2001. "Hit and run" transformation leading to carcinogenesis. Dev. Biol. 106:77-82
126. Mednick, S. A., et al. 1988. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45:189-92.
127. de Messias, E. L. M., et al. 2001. Schizophrenia and season of birth in a tropical region: Relationship to rainfall. Schizophr. Res. 48:227-34.
128. Miller, J., et al. 1976. Studies on the antimicrobial activity of amniotic fluid. Am. J. Obstet. Gynecol. 125:212-14.
129. Minto, A., and F. J. Roberts. 1959. The psychiatric complications of toxoplasmosis. Lancet 1:1180-82.
130. Morse, K. T. 1956. Some protozoan diseases of man and animals: Anaplasmosis, Babesiosis, and Toxoplasmosis. New York: Annals of the New York Academy of Sciences.
131. Müller, N., et al. 2000. The immune system and schizophrenia: An integrative review. Ann. NY Acad. Sci. 917:456-67.
132. Nevels, M., et al. 2001. "Hit-and-run" transformation by adenovirus oncogenes. J. Virol. 75:3089-94.
133. Nieto, F. J. 1999. Viruses and atherosclerosis: A critical review of the epidemiologic evidence. Am. Heart. J. 138:S453-60.
134. Niizato, K., et al. 2001. Astroglial function of schizophrenic brain: A study using lobotomized brain. Clin. Neurosci. Neuropathol. 12:1457-60.
135. Olsen, C. W. 1999. Vaccination of cats against emerging and reemerging zoonotic pathogens. Adv. Vet. Med. 41:333-46.
136. Onstad, S., et al. 1991. Mental disorders in first-degree relatives of schizophrenics. Acta. Psychiatr. Scand. 83:463-67.
137. Osby, U., et al. 2000. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr. Res. 45:21-28.
138. Pacsa, A. S., and B. Pejtsik. 1977. Impairment of immunity during pregnancy and antiviral effect of amniotic fluid. Lancet 1:330-31.
139. Pallast, E. G. M., et al. 1994. Excess seasonality of births among patients with schizophrenia and seasonal ovopathy. Schizophr. Bull. 20:269-76.
140. Pariser, S. F., J. Zunich, and E. R. Pinta. 1978. Toxoplasmosis masquerading as a psychotropic side effect. J. Clin. Psychiatry 39:631-32.
141. Parker, G., et al. 2000. Season of birth in schizophrenia: No latitude at the equator. Br. J. Psychiatry 176:68-71.
142. Parmley, S., T. Slifer, and F. Araujo. 2002. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts. J. Infect. Dis. 185:S90-95.
143. Peterson, D. R., M. K. Cooney, and R. P. Beasley. 1974. Prevalence of antibody to Toxoplasma gondii among Alaskan natives: Relation to exposure to Felidae. J. Infect. Dis. 130:557-63.
144. Peterson, D. R., E. Tronca, and P. Bonin. 1972. Human toxoplasmosis prevalence and exposure to cats. Am. J. Epidemiol. 96:215-18.
145. Peterson, P. K., et al. 1995. Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. J. Infect. Dis. 171:516-18.
146. Peyron, F., and M. Wallon. 2001. Options for the pharmacotherapy of toxoplasmosis during pregnancy. Expert. Opin. Pharmacother. 2:1269-74.
147. Piekarski, G. 1981. Behavioral alterations caused by parasitic infection in case of latent Toxoplasma infection. Zentralbl. Bakteriol., Mikrobiol. Hyg. 250:403-6.
148. Rawlins, S. 2001. Nonviral sexually transmitted infections. J. Obstet. Gynecol. Neonatal Nurs. 30:324-31.
149. Remington, J. S., and E. N. Cavanaugh. 1965. Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N. Engl. J. Med. 273:1308-10.
150. Remington, J. S., and J. O. Klein. 1976. Infectious diseases of the fetus and newborn infant. Philadelphia: W. B. Saunders.
151. Remington, J. S., J. W. Newell, and E. Cavanaugh. 1964. Spontaneous abortion and chronic toxoplasmosis. Obstet. Gynecol. 24:25-31.
152. Rieder, R. O., et al. 1975. The offspring of schizophrenics: Fetal and neonatal deaths. Arch. Gen. Psychiatry 32:200-211.
153. Rinkel, M., et al. 1952. Experimental schizophrenia-like symptoms. Am. J. Psychiatry 108:572-78.
154. Roberts, F., et al. 2000. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol. 22:1-5.
155. de Roever-Bonnet, H., J. G. Koppe, and D. H. Loewer-Sieger. 1979. Follow-up of children with congenital toxoplasmosis infections and children who became serologically negative after 1 year of age, all born in 1964-1965. In PerinataI Medicine: Sixth European Congress, Vienna, ed. O. Thalhammer, K. Baumgarten, and A. Pollak. Stuttgart: Georg Thieme.
156. Roghmann, M. C., et al. 1999. Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland. Am. J. Trop. Med. Hyg. 60:790-92.
157. Sabin, A. B., et al. 1952. Present status of clinical manifestations of toxoplasmosis in man. JAMA 150:1063-69.
158. Saijo, T., et al. 2001. Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study. Psychiatry Clin. Neurosci. 55:41-47.
159. Sampath, H. M. 1974. Prevalence of psychiatric disorders in a southern Baffin Island Eskimo settlement. Can. Psych. Ass. J. 19:363-67.
160. Sanghi, A., et al. 1997. Zoonotic and viral infection in fetal loss after 12 weeks. Br. J. Obstet. Gynaecol. 104:942-45.
161. Schwab, S. G., et al. 2002. Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia. Am. J. Med. Genet. 114:315-20.
162. Schwarz, M. J., et al. 2001. The Th2-hypothesis of schizophrenia: A strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med. Hypotheses 56:483-86.
163. Sham, P. 1989. Schizophrenia, season of birth, and maternal age. Br. J. Psychiatry 155:128.
164. Sham, P. C., C. J. MacLean, and K. S. Kendler. 1993. Risk of schizophrenia and age difference with older siblings: Evidence for a maternal viral infection hypothesis? Br. J. Psychiatry 163:627-33.
165. Shenton, M. E., et al.. 2001. A review of MRI findings in schizophrenia. Schizophr. Res. 49:1-52.
166. Sherrington, R., et al. 1988. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336:164-67.
167. Shima, K., et al. 2000. Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan. Br. J. Oral Maxillofac. Surg. 38:445-50.
168. Silverman, B., and G. Varela. 1958. Toxoplasmosis, mental disease and LSD-25. Rev. Inst. Salub. Enf. Trop. Mexico 18:191-94.
169. Sivakumar, K., and C. I. Okocha. 1992. Neurosyphilis and schizophrenia. Br. J. Psychiatry 161:251-54.
170. Sobel, D. E. 1961. Infant mortality and malformations in children of schizophrenic women. Psychiatr. Q. 35:60-65.
171. Spence, J. B., C. P. Beattie, J. Faulkner, L. Henry, and W. A. Watson. 1978. Toxoplasma gondii in the semen of rams. Vet. Rec. 102:38-39.
172. Stern, H., et al. 1969. Microbial causes of mental retardation: The role of prenatal infections with cytomegalovirus, rubella virus, and Toxoplasma. Lancet 2:443-48.
173. Stibbs, H. H. 1985. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann. Trop. Med. Parasitol. 79:153-57.
174. Straub, R. E., et al. 2002. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatry 7:542-59.
175. Stray-Pedersen, B., and A.-M. Lorentzen-Styr. 1977. Uterine Toxoplasma infections and repeated abortions. Am. J. Obstet. Gynecol. 128:716-21.
176. Suvisaari, J., et al. 1999. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am. J. Psychiatry 156:1100-1102.
177. Suzuki, Y. 2002. Host resistance in the brain against Toxoplasma gondii. J. Infect. Dis. 185: S58-65.
178. Suzuki, Y., et al. 1996. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J. Infect. Dis. 173:265-68.
179. Taylor-Robinson, A. W. 2000. The sequestration hypothesis: An explanation for the sensitivity of malaria parasites to nitric oxide-mediated immune effector function in vivo. Med. Hypotheses 54:638-41.
180. Thaker, G. K., and W. T. Carpenter, Jr. 2001. Advances in schizophrenia. Nat. Med. 7:667-71.
181. Tjalma, W., et al. 1998. Discordant prenatal diagnosis of congenital toxoplasmosis in a dizygotic twin pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 79:107-8.
182. Torrey, E. F. 1980. Schizophrenia and civilization. New York: Jason Aronson.
183. Torrey, E. F. 1992. Are we overestimating the genetic contribution to schizophrenia? Schizophr. Bull. 18:159-70.
184. Torrey, E. F. 1999. Epidemiological comparison of schizophrenia and bipolar disorder. Schizophr. Res. 39:101-6.
185. Torrey, E. F., A. E. Bowler, and K. Clark. 1997. Urban birth and residence as risk factors for psychoses: An analysis of 1880 data. Schizophr. Res. 25:169-76.
186. Torrey, E. F., R. Rawlings, and R. H. Yolken. 2000. The antecedents of psychoses: A case-control study of selected risk factors. Schizophr. Res. 46:17-23.
187. Torrey, E. F., B. B. Torrey, and M. R. Petersen. 1977. Seasonality of schizophrenic births in the United States. Arch. Gen. Psychiatry 34:1065-70.
188. Torrey, E. F., and R. H. Yolken. 1995. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr. Bull. 21:167-71.
189. Torrey, E. F., and R. H. Yolken. Submitted. Toxoplasma gondii may contribute to the etiology of schizophrenia. Emerg. Infect. Dis.
190. Torrey, E. F., et al. 1993. Seasonality of schizophrenia and stillbirths. Schizophr. Bull. 19:557-62.
191. Torrey, E. F., et al. 2001. Risk factors and confounders in the geographical clustering of schizophrenia. Schizophr. Res. 49:295-99.
192. Tsuang, M. T., W. S. Stone, and S. V. Faraone. 2001. Genes, environment and schizophrenia. Br. J. Psychiatry Suppl. 40:S18-24.
193. Varela, G., A.Vázquez, and J. Torroella. 1956. Probable existencia de la dietilamida del acido d-lisergico en la infeccion por Toxoplasma gondii. Rev. Inst. Salub. Enf. Trop. Mexico. 16:29-32.
194. Videbech, T., A. Weeke, and A. Dupont. 1974. Endogenous psychoses and season of birth. Acta. Psychiatr. Scand. 50:202-18.
195. Villena, I., et al. 1998. Prenatal diagnosis of congenital toxoplasmosis transmitted by an immunocompetent woman infected before conception. Reims Toxoplasmosis Group. Prenat. Diagn. 18:1079-81.
196. Vogel, F., and A. G. Motulsky. 1997. Human genetics: Problems and approaches, 3rd ed. Berlin: Springer.
197. Wallace, G. D., L. Marshall, and M. Marshall. 1972. Cats, rats and toxoplasmosis on a small Pacific island. Am. J. Epidemiol. 95:475-82.
198. Waltrip, R. W., et al. 1997. Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophr. Res. 23:253-57.
199. Webster, J. P. 1994. The effects of Toxoplasma gondii and other parasites on activity levels in wild brown rats, Rattus norvegicus. Parasitology 109:583-89.
200. Webster, J. P. 2001. Rats, cats, people and parasites: The impact of latent toxoplasmosis on behaviour. Microbe Infect. 3:1037-45.
201. Webster, J. P., C. F. A. Branton, and D. W. MacDonald. 1994. Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Raitus norvegicus. Parasitology 109:37-43.
202. Weinberger, D. R. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44:660-69.
203. Weinman, D., and H. J. Klatchko. 1950. Description of toxin in toxoplasmosis. Yale J. Biol. Med. 22:323-28.
204. Werner, H., K. N. Masihi, and U. Senk. 1981. Latent Toxoplasma-infection as a possible risk factor for CNS disorders. Zentralbl. Bakteriol., Mikrobiol. Hyg. 250:368-75.
205. Westergaard, T., et al. 1999. Exposure to prenatal and childhood infections and the risk of schizophrenia: Suggestions from a study of sibship characteristics and influenza prevalence. Arch. Gen. Psychiatry 56:993-98.
206. Woodworth, H. C., and D. Weinman Il. 1960. Studies on the toxin of Toxoplasma (toxotoxin). J. Infect. Dis. 107:318-24.
207. Yap, G. S., et al. 2001. A heritable defect in IL-12 signaling in B10.Q/J mice. II. Effect on acute resistance to Toxoplasma gondii and rescue by IL-18 treatment. J. Immunol. 166:5720-25.
208. Yolken, R. H., and E. F. Torrey. 1995. Viruses, schizophrenia, and bipolar disorder. Clin. Microbiol. Rev. 8:131-45.
209. Yolken, R. H., and E. F. Torrey. 1997. Viruses as etiologic agents of schizophrenia. Adv. Biol. Psychiatry 18:1-12.
210. Yolken, R. H., et al. 2001. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin. Infect. Dis. 32:842-44.
211. Zenner, L., et al. 1999. Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components. Parasite. Immunol. 21:261-72.